A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.
Immunocompromised people with persistent COVID infections can harbor drug-resistant variants of the virus, which have the potential to spread, researchers at Weill Cornell Medicine, the College of Veterinary Medicine and the NIH have found.
Cornell researchers develop affordable test for iron deficiency, which affects 2 billion people, disproportionately impacting women of childbearing age as well as infants and young children.
Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help to control inflammation-related conditions.
A mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma compared with other variants, according to a multicenter study conducted at Weill Cornell Medicine, NewYork-Presbyterian and other institutions.
Scientists at Weill Cornell Medicine in Qatar have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules in blood, urine and saliva samples from 391 volunteers.
Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
A classic psychedelic was found to activate a cell type in the brain of mice and rats that silences other neighboring neurons, providing insight into how such drugs reduce anxiety.
For undergraduate would-be entrepreneurs, this competition encourages examining micro- or macro-level problems and envisioning ways to fix them via innovative business ventures.